154 related articles for article (PubMed ID: 12101794)
1. [Do mobile telephones have adverse effects on the functions of implantable cardioverter defibrillators?].
Tandoğan I; Ileri M; Yetkin E; Temizhan A; Aras D; Sezgin AT; Biyikoğlu F; Saşmaz A
Anadolu Kardiyol Derg; 2002 Mar; 2(1):45-8, AXVII. PubMed ID: 12101794
[TBL] [Abstract][Full Text] [Related]
2. In-vivo testing of digital cellular telephones in patients with implantable cardioverter-defibrillators.
Chiladakis JA; Davlouros P; Agelopoulos G; Manolis AS
Eur Heart J; 2001 Aug; 22(15):1337-42. PubMed ID: 11465966
[TBL] [Abstract][Full Text] [Related]
3. [Editorial comment: mobile telephones and implantable cardioverter-defibrillators].
Demirkan D
Anadolu Kardiyol Derg; 2002 Mar; 2(1):49. PubMed ID: 12793432
[No Abstract] [Full Text] [Related]
4. Implantable cardioverter defibrillators and cellular telephones: is there any interference?
Occhetta E; Plebani L; Bortnik M; Sacchetti G; Trevi G
Pacing Clin Electrophysiol; 1999 Jul; 22(7):983-9. PubMed ID: 10456625
[TBL] [Abstract][Full Text] [Related]
5. The effects of mobile phones on pacemaker function.
Tandogan I; Temizhan A; Yetkin E; Guray Y; Ileri M; Duru E; Sasmaz A
Int J Cardiol; 2005 Aug; 103(1):51-8. PubMed ID: 16061124
[TBL] [Abstract][Full Text] [Related]
6. Interference with cardiac pacemakers by cellular telephones.
Hayes DL; Wang PJ; Reynolds DW; Estes M; Griffith JL; Steffens RA; Carlo GL; Findlay GK; Johnson CM
N Engl J Med; 1997 May; 336(21):1473-9. PubMed ID: 9154765
[TBL] [Abstract][Full Text] [Related]
7. Effects of mobile telephones on the function of implantable cardioverter defibrillators.
Tandogan I; Ozin B; Bozbas H; Turhan S; Ozdemir R; Yetkin E; Topal E
Ann Noninvasive Electrocardiol; 2005 Oct; 10(4):409-13. PubMed ID: 16255750
[TBL] [Abstract][Full Text] [Related]
8. Reduction of ventricular tachyarrhythmia by treatment of atrial fibrillation in ICD patients with dual-chamber implantable cardioverter/defibrillators capable of atrial therapy delivery: the REVERT-AF Study.
Gradaus R; Seidl K; Korte T; Himmrich E; Wieneke H; Schuchert A; Bauer W; Gerss J; Wollmann CG; Borggrefe M; Böcker D
Europace; 2007 Jul; 9(7):534-9. PubMed ID: 17440005
[TBL] [Abstract][Full Text] [Related]
9. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
[TBL] [Abstract][Full Text] [Related]
10. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator.
Korte T; Köditz H; Niehaus M; Paul T; Tebbenjohanns J
Pacing Clin Electrophysiol; 2004 Jul; 27(7):924-32. PubMed ID: 15271011
[TBL] [Abstract][Full Text] [Related]
11. [The absence of interference between GSM mobile telephones and implantable defibrillators: an in-vivo study. Groupe Systèmes Mobiles].
Sanmartín M; Fernández Lozano I; Márquez J; Antorrena I; Bautista A; Silva L; Ortigosa J; de Artaza M
Rev Esp Cardiol; 1997 Oct; 50(10):715-9. PubMed ID: 9417561
[TBL] [Abstract][Full Text] [Related]
12. Induction ovens and electromagnetic interference: what is the risk for patients with implantable cardioverter defibrillators?
Binggeli C; Rickli H; Ammann P; Brunckhorst C; Hufschmid U; Luechinger R; Duru F
J Cardiovasc Electrophysiol; 2005 Apr; 16(4):399-401. PubMed ID: 15828884
[TBL] [Abstract][Full Text] [Related]
13. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
Whang W; Mittleman MA; Rich DQ; Wang PJ; Ruskin JN; Tofler GH; Muller JE; Albert CM;
Circulation; 2004 Mar; 109(11):1386-91. PubMed ID: 14993132
[TBL] [Abstract][Full Text] [Related]
14. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
Wilkoff BL;
Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
[TBL] [Abstract][Full Text] [Related]
15. Comparison of ventricular arrhythmia burden, therapeutic interventions, and survival, in patients < 75 and patients >or= 75 years of age treated with implantable cardioverter defibrillators.
Ermis C; Zhu AX; Vanheel L; Sakaguchi RN; Lurie KG; Lu F; Benditt DG
Europace; 2007 May; 9(5):270-4. PubMed ID: 17371804
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of patients who received implantable cardioverter defibrillators for stable ventricular tachycardia.
Glikson M; Lipchenca I; Viskin S; Ballman KV; Trusty JM; Gurevitz OT; Luria DM; Eldar M; Hammill SC; Friedman PA
J Cardiovasc Electrophysiol; 2004 Jun; 15(6):658-64. PubMed ID: 15175060
[TBL] [Abstract][Full Text] [Related]
17. Interference of electrical dental equipment with implantable cardioverter-defibrillators.
Brand HS; Entjes ML; Nieuw Amerongen AV; van der Hoeff EV; Schrama TA
Br Dent J; 2007 Nov; 203(10):577-9. PubMed ID: 18037843
[TBL] [Abstract][Full Text] [Related]
18. Electrocautery-induced ventricular tachycardia and fibrillation during device implantation and explantation.
Lo R; Mitrache A; Quan W; Cohen TJ
J Invasive Cardiol; 2007 Jan; 19(1):12-5. PubMed ID: 17297178
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis.
Aizer A; Stern EH; Gomes JA; Teirstein AS; Eckart RE; Mehta D
Am J Cardiol; 2005 Jul; 96(2):276-82. PubMed ID: 16018857
[TBL] [Abstract][Full Text] [Related]
20. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.
Spencker S; Coban N; Koch L; Schirdewan A; Müller D
Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
